# A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

> **NCT06347159** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Edgewise Therapeutics, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** EDG-7500
- **DRUG:** EDG-7500

## Key facts

- **NCT ID:** NCT06347159
- **Lead sponsor:** Edgewise Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-11
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06347159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06347159, "A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06347159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*